Cite
HARVARD Citation
McGuinness, J. et al. (2021). Antibody-drug conjugates in metastatic triple negative breast cancer: a spotlight on sacituzumab govitecan, ladiratuzumab vedotin, and trastuzumab deruxtecan. Expert opinion on biological therapy. pp. 903-913. [Online].